Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2010 1
2011 1
2012 1
2013 4
2014 1
2017 1
2019 4
2020 4
2021 5
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Pathological processes and pretreatment cytologic diagnosis of neuroendocrine carcinoma of the endometrium: addendum report of the Kansai Clinical Oncology Group/Intergroup study in Japan.
Matsumoto H, Nasu K, Shikama A, Shiozaki T, Futagami M, Kai K, Mori T, Yano M, Yamada T, Teramoto N. Matsumoto H, et al. Among authors: shiozaki t. Med Mol Morphol. 2021 Sep;54(3):237-244. doi: 10.1007/s00795-021-00288-4. Epub 2021 May 2. Med Mol Morphol. 2021. PMID: 33934220 Clinical Trial.
Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
Yamamoto K, Nagao S, Tsu T, Matsushima T, Ishido Y, Narita M, Suzuki K, Nakazawa H, Shibutani T, Jimi T, Yano H, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S. Yamamoto K, et al. Among authors: shiozaki t. J Obstet Gynaecol Res. 2021 Apr;47(4):1536-1543. doi: 10.1111/jog.14670. Epub 2021 Jan 20. J Obstet Gynaecol Res. 2021. PMID: 33469981
Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
Kai K, Nasu K, Nishida H, Daa T, Shikama A, Shiozaki T, Kurakazu M, Yano M, Imamura Y, Tokunaga H, Tasaki K, Iida Y, Yamada Y, Morisawa H, Nakagawa S, Fujimoto E, Tsuruta T, Matsumoto H, Arakawa A, Nonaka M, Takano H, Ushiwaka T, Mori T, Ito K, Motohashi T, Teramoto N, Yamada T. Kai K, et al. Among authors: shiozaki t. Neuroendocrinology. 2021;111(4):320-329. doi: 10.1159/000506743. Epub 2020 Feb 25. Neuroendocrinology. 2021. PMID: 32097950
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Nagao S, Kogiku A, Suzuki K, Shibutani T, Yamamoto K, Jimi T, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S. Nagao S, et al. Among authors: shiozaki t. J Ovarian Res. 2020 Feb 7;13(1):14. doi: 10.1186/s13048-020-0617-y. J Ovarian Res. 2020. PMID: 32028974 Free PMC article. Clinical Trial.
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.
Shibutani T, Nagao S, Suzuki K, Kaneda M, Yamamoto K, Jimi T, Yano H, Kitai M, Shiozaki T, Matsuoka K, Sudo T, Yamaguchi S. Shibutani T, et al. Among authors: shiozaki t. Int J Clin Oncol. 2020 Mar;25(3):502-507. doi: 10.1007/s10147-019-01567-y. Epub 2019 Nov 1. Int J Clin Oncol. 2020. PMID: 31677021
25 results